USPTO Examiner BURNETTE GABRIELLA E - Art Unit 3781

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18617488Scalp Treatment Applicator For Applying Scalp Treatment CompositionsMarch 2024March 2026Allow2420YesNo
18615456Syringe AdapterMarch 2024February 2026Allow2320NoNo
18421902BOOTH FOR APPLICATION OF TANNING FLUIDSJanuary 2024September 2024Allow820YesNo
18419431PERINEAL THERMAL PACK WITH IMPROVED LIQUID CONTAINMENTJanuary 2024May 2025Abandon1610NoNo
18397762WOUND DRESSING SEALANT AND USE THEREOFDecember 2023February 2025Allow1410YesNo
18540323APPARATUS AND METHOD OF USING A UROSTOMY BELTDecember 2023February 2026Allow2610NoNo
18538759DISPOSABLE CARTRIDGE FOR VACUUM ACTUATED FLUID DELIVERYDecember 2023May 2025Allow1701YesNo
18377657LAPAROSCOPIC SURGICAL DRAIN AND LAPAROSCOPEOctober 2023January 2025Allow1530NoNo
18479147ABSORBENT CORE HAVING SWELLING CHAMBEROctober 2023January 2025Allow1510NoNo
18471493OSMOTIC SANITARY COLLECTION BAGSeptember 2023January 2025Allow1510YesNo
18239624INSTILLATION CARTRIDGE FOR VACUUM ACTUATED FLUID DELIVERYAugust 2023September 2025Allow2521NoNo
18305098Surgical Infant DiaperApril 2023January 2024Allow900YesNo
18191396SYSTEMS AND METHODS FOR PRIMING BODY PARTS BEFORE APPLYING COSMETICSMarch 2023February 2025Allow2230YesNo
18112533ABSORBENT ARTICLE WITH SELECTIVELY POSITIONED WAIST CONTAINMENT MEMBERFebruary 2023October 2025Allow3140NoYes
18168277Device for Delivery of Skin Care CompositionFebruary 2023November 2023Allow910NoNo
17838226METHOD OF MAKING A READY-TO-USE CATHETER ASSEMBLY AND A READY-TO-USE CATHETER ASSEMBLYJune 2022June 2025Abandon3601NoNo
17741828BONE FRAGMENT AND TISSUE PROCESSING SYSTEMMay 2022January 2024Allow2010YesNo
17713377Absorbent Underwear InsertApril 2022March 2024Abandon2410YesNo
17763681SYSTEMS AND APPROACHES FOR DRUG DELIVERY DEVICE RECONSTITUTIONMarch 2022June 2025Allow3820NoNo
17699304MULTI-PIECE ABSORBENT ARTICLES WITH LEG CUFFSMarch 2022March 2024Abandon2410NoNo
17692749SURFACE ENERGY ENHANCING FLUID AND APPLICATIONS ON LIVING TISSUESMarch 2022June 2023Abandon1520YesNo
17688563PERINEAL THERMAL PACK WITH IMPROVED LIQUID CONTAINMENTMarch 2022March 2024Abandon2520NoNo
17637814APPLICATION AID FOR OSTOMY DEVICEFebruary 2022October 2025Allow4400NoNo
17591936Feminine Napkin AssemblyFebruary 2022December 2025Allow4630YesNo
17597673FLUID COLLECTION DEVICES INCLUDING AT LEAST ONE SHAPE MEMORY MATERIALJanuary 2022February 2025Allow3720YesNo
17626219ABSORBENT ARTICLEJanuary 2022April 2025Allow3920YesNo
17625887FLUID COLLECTION DEVICES, SYSTMES AND METHODSJanuary 2022February 2026Allow5001YesNo
17644493Ear Ring Hole Cotton SwabDecember 2021August 2024Abandon3220YesNo
17541585METHOD AND APPARATUS FOR ASSEMBLING APERTURED ELASTIC LAMINATESDecember 2021September 2024Allow3410NoNo
17616447WETNESS MONITORING SYSTEM AND METHODDecember 2021March 2026Abandon5110NoNo
17529913PANTS-TYPE DISPOSABLE DIAPER AND METHOD FOR MANUFACTURING PANTS-TYPE DISPOSABLE DIAPERNovember 2021October 2024Abandon3501NoNo
17523908Device for Positioning an Absorptive Matrix Element within a Body Cavity and Kit for Collecting Biological SecretionsNovember 2021March 2026Allow5220NoYes
17610657BIOFLUID SHUNT VALVE WITH SHEATH AND MONITORING DEVICENovember 2021October 2025Allow4720YesNo
17606801ABSORBENT ARTICLEOctober 2021May 2025Abandon4320NoNo
17606055Sensor Patch for Attachment to a Base PlateOctober 2021January 2026Allow5020YesNo
17598526SUCTION BAG FOR MEDICAL OR SURGICAL USE, AND SUCTION BAG ARRANGEMENTSeptember 2021September 2025Allow4840NoNo
17479189TAMPON WITH APPLICATOR SUBSTANTIALLY FREE OF COMPONENTS DERIVED FROM PETROLEUMSeptember 2021January 2025Allow3930NoNo
17439847ABSORBENT ARTICLE HAVING APERTURED SIDE PANELSSeptember 2021March 2026Abandon5440NoNo
17439621DIAPER WITH COLLECTION POUCHSeptember 2021July 2025Abandon4620NoNo
17471085Diaper Assist RingSeptember 2021April 2022Allow810YesNo
17408517SURGERY DRAINAGE TUBEAugust 2021October 2022Allow1410NoNo
17427271REGIONAL DECOAGULATION SYSTEM FOR EXTRACORPOREAL BLOOD-CIRCULATION CIRCUITJuly 2021August 2025Allow4910YesNo
17418411Device For Male Urinary IncontinenceJune 2021September 2025Abandon5020NoNo
17354301METERED DOSE TOPICAL APPLICATORJune 2021March 2024Allow3300YesNo
17295642Unfoldable Feminine Sanitary TowelMay 2021April 2024Allow3510NoNo
17239080GRIPPER SLEEVE FOR URINARY CATHETERApril 2021May 2023Allow2510NoNo
17286539Topical Medicine Applicator for ScalpApril 2021December 2024Abandon4420YesNo
17274242MULTI-LAYERED ABSORBENT ARTICLEMarch 2021August 2025Allow5440NoNo
17271703Hematostick/HematoDartFebruary 2021December 2025Allow5740YesNo
17184827ABSORBENT CORE HAVING SWELLING CHAMBERFebruary 2021September 2023Allow3010NoNo
17269430OCULAR DEVICE FOR TREATING GLAUCOMA AND RELATED MINIMALLY INVASIVE GLAUCOMA SURGERY METHODFebruary 2021March 2024Allow3700YesNo
17267401Absorbent ArticleFebruary 2021September 2024Abandon4301NoNo
17265950SHEET MEMBER EXHIBITING UNEVENNESS, ABSORBENT ARTICLE EQUIPPED WITH SAME AND PRODUCING METHOD THEREFORFebruary 2021July 2024Abandon4201NoNo
17263781FEMININE HYGIENE ABSORBENT ARTICLEJanuary 2021September 2024Abandon4410NoNo
17262903ABSORBENT ARTICLE FOR MENJanuary 2021February 2024Abandon3610NoNo
17145994LEAK-RESISTANT BANDAGE SYSTEMS AND METHODS WITH HYDROPHILIC FOAM WOUND INSERT FOR FLUID-INSTILLATION AND/OR NEGATIVE-PRESSURE WOUND THERAPIESJanuary 2021December 2025Allow5950YesNo
17059653A DEVICE FOR COLLECTING MIDSTREAM URINE FROM A HUMAN INDIVIDUALNovember 2020April 2025Allow5220NoNo
17055967METHODS OF MAKING SLEEVED HYDROPHILIC CATHETER ASSEMBLIESNovember 2020May 2025Allow5430YesNo
17092403OPTICAL THERAPEUTIC APPARATUS AND OPTICAL THERAPEUTIC METHODNovember 2020November 2024Abandon4820YesNo
17053361Male Urinary Incontinence DeviceNovember 2020June 2025Abandon5540NoNo
17053360A male urinary incontinence deviceNovember 2020February 2024Allow3920NoNo
17250022MULTI-PURPOSE DISPOSABLE UNDERWEARNovember 2020August 2025Allow5730NoNo
17051616Systems and Methods for Treating or Preventing Right and/or Left Cardiac Overload and Ventricular DisfunctionOctober 2020November 2024Abandon4911NoNo
17082248Protective Shield BlockerOctober 2020October 2022Abandon2320NoNo
17069404Topical Ocular Delivery of Fluids with Controlled Mass Dosing and Wireless CommunicationOctober 2020February 2025Allow5230YesNo
17044810FUNCTIONAL DIAPEROctober 2020March 2024Allow4210NoNo
17031964LIQUID APPLICATORSeptember 2020November 2023Abandon3810NoNo
17027872METHOD AND APPARATUS FOR APPLYING A TOPICAL SOLUTIONSeptember 2020September 2023Allow3610YesNo
17025825SURFACE ENERGY ENHANCING FLUID AND APPLICATIONS ON LIVING TISSUESSeptember 2020June 2023Abandon3250YesNo
16992752LIQUID TRANSFER DEVICE WITH INTEGRAL TELESCOPIC VIAL ADAPTER FOR USE WITH INFUSION LIQUID CONTAINER AND DISCRETE INJECTION VIALAugust 2020June 2023Allow3410NoNo
16989996NEGATIVE PRESSURE WOUND DRESSING MANAGEMENT SYSTEMAugust 2020December 2024Allow5240YesNo
16989874Sterile Applicator Assembly with Hollow Microneedle ArrayAugust 2020February 2021Allow610NoNo
16966187BLOOD APPLICATOR FOR TISSUE TREATMENTJuly 2020March 2024Abandon4420NoNo
16904868FLUID COLLECTION DEVICES AND METHODS OF USING THE SAMEJune 2020September 2024Allow5170YesNo
16879184METAL OXIDE AND POLYMER CONTROLLED DELIVERY SYSTEMS, SUNSCREENS, TREATMENTS AND TOPICAL COATING APPLICATORSMay 2020December 2022Abandon3110NoNo
16879733LIQUID ABSORBING BAGMay 2020August 2022Abandon2720NoNo
16868484LIMB-MOUNTED NOSE WIPING DEVICEMay 2020October 2021Allow1700YesNo
16866601Configurable Absorbent ArticlesMay 2020November 2022Abandon3020NoNo
16861941GRIPPER SLEEVE FOR URINARY CATHETERApril 2020February 2021Allow1020YesNo
16849432METHOD OF APPLYING FASTENER ELEMENTS FOR DISPOSABLE ABSORBENT GARMENTApril 2020March 2026Allow6050YesNo
16845356SWAB ASSEMBLY AND SYSTEMApril 2020September 2021Abandon1720NoNo
16652987BIODEGRADABLE UNDERWEARApril 2020November 2023Abandon4310NoNo
16649235WOUND HEALING DEVICE AND METHODS FOR WOUND HEALINGMarch 2020October 2024Abandon5520NoNo
16824934TAMPON AND APPLICATOR ASSEMBLY WITH ADVANTAGEOUSLY-SHAPED GRIPPING PORTIONMarch 2020July 2025Allow6060NoYes
16815020ABSORBENT ARTICLE, ENCLOSING PANTS, AND METHOD FOR WEARING COMBINATION THEREOFMarch 2020March 2023Allow3711NoNo
16792811MALE GENITAL DISCHARGE ABSORPTION AND RETENTION DEVICEFebruary 2020October 2022Abandon3210NoNo
16789522FEMININE HYGIENE PAD WITH HYDROPHILIC NONWOVEN TOPSHEET HAVING ENHANCED SKIN FEEL AND OBSCURING PERFORMANCEFebruary 2020March 2024Abandon4920NoNo
16790201ANIMAL URINE COLLECTION AND MONITORING SYSTEMFebruary 2020June 2023Abandon4010NoNo
16779436WOUND DRESSING SEALANT AND USE THEREOFJanuary 2020July 2023Allow4120YesNo
16632225UNDERPANTS-TYPE DISPOSABLE DIAPERJanuary 2020June 2022Allow2910YesNo
16743513INCONTINENCE PANT AND INCONTINENCE PANT SYSTEMJanuary 2020April 2022Allow2730YesNo
16698050WOUND DRESSING AND METHOD OF TREATMENTNovember 2019October 2025Allow6060YesNo
16697459OSMOTIC SANITARY COLLECTION BAGNovember 2019June 2023Allow4310YesNo
16611285ABSORBENT PANTS HAVING A WAISTBAND WITH A REAR POCKETNovember 2019January 2024Abandon5130NoNo
16669710DIAPER WITH ABSORBENT FLAPOctober 2019September 2021Abandon2310NoNo
16664810COMPACT TAMPON APPLICATOROctober 2019November 2022Abandon3610NoNo
16655752ABSORBENT ARTICLE WITH AEROGEL ABSORBENTOctober 2019January 2023Abandon3910NoNo
16541211ABSORBENT ARTICLES HAVING A CONTRASTING LAYER AND A MASKING LAYERAugust 2019June 2023Abandon4620NoNo
16540336MEDICAL DRESSING INTERFACE DEVICES, SYSTEMS, AND METHODSAugust 2019June 2022Allow3411YesNo
16484477TRANSDERMAL DRUG DELIVERY DEVICES AND METHODSAugust 2019December 2022Abandon4010NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BURNETTE, GABRIELLA E.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
1
(50.0%)
Examiner Reversed
1
(50.0%)
Reversal Percentile
79.3%
Higher than average

What This Means

With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
20
Allowed After Appeal Filing
6
(30.0%)
Not Allowed After Appeal Filing
14
(70.0%)
Filing Benefit Percentile
45.7%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 30.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner BURNETTE, GABRIELLA E - Prosecution Strategy Guide

Executive Summary

Examiner BURNETTE, GABRIELLA E works in Art Unit 3781 and has examined 240 patent applications in our dataset. With an allowance rate of 54.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 41 months.

Allowance Patterns

Examiner BURNETTE, GABRIELLA E's allowance rate of 54.6% places them in the 15% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by BURNETTE, GABRIELLA E receive 2.34 office actions before reaching final disposition. This places the examiner in the 67% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BURNETTE, GABRIELLA E is 41 months. This places the examiner in the 22% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +40.6% benefit to allowance rate for applications examined by BURNETTE, GABRIELLA E. This interview benefit is in the 88% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 21.5% of applications are subsequently allowed. This success rate is in the 26% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 10.8% of cases where such amendments are filed. This entry rate is in the 11% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 80.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 64% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 81.8% of appeals filed. This is in the 75% percentile among all examiners. Of these withdrawals, 55.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 43.1% are granted (fully or in part). This grant rate is in the 35% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 3.1% of allowed cases (in the 74% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.